ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 998

Transcription Factor Fli-1 Impacts Renal IL-17 Expression in Adult MRL/Lpr Mouse Despite Similar Interstitial Immune Cell Infiltration into the Kidney

Shuzo Sato1, Xian Zhang2, Yuya Fujita1, Makiko Yashiro1, Tomoyuki Asano1, Hiroko Kobayashi1, Hiroshi Watanabe1 and Kiyoshi Migita3, 1Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan, 2Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 3Fukushima Medical University, School of Medicine, Fukushima, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus nephritis and transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Cytokines and Cell Trafficking Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fli-1 is a member of Ets transcription factor and plays an important role in lupus nephritis development. Reduced Fli-1 expression (heterozygote Fli-1: Fli-1+/-) results in improvement of kidney inflammation and prolongs overall survival in lupus model mouse. Previously, we have reported that Fli-1 directly regulates cytokine/chemokine expression (MCP-1, RANTES, CXCL2, IL-6, and G-CSF) and impacts lupus nephritis development in lupus model mouse. IL-17 is a cytokine with powerful inflammatory properties. Past reports indicate that IL-17 is associated with disease activity in patients with lupus nephritis. The relationship between Fli-1 and IL-17 is unknown. The aim of this study is to elucidate whether reduced Fli-1 expression affects IL-17 production and impacts lupus nephritis development into the kidney.

Methods: Serum IL-17 concentrations of adult (4-months-old or older) Wild-type (WT) and Fli-1+/- MRL/lpr mice were measured by ELISA and compared between the two groups. Kidneys were removed from these mice and evaluated using pathology scoring system (glomerular and interstitial lesions). Immunostaining of IL-17 in the kidney was also performed and compared between the two groups. Expression of mRNA of IL-17, IL-18 and IL-1ƒÀin the kidney tissue were also compared.

Results: Serum IL-17 concentrations were relatively decreased but not significant in Fli-1+/- MRL/lpr mice (WT: 55.7 vs Fli-1+/-: 3.12 pg/mL, respectively, p=0.35). Relative mRNA expression of IL-17 in the kidney was decreased (19.7%) in Fli-1+/- MRL/lpr mice compared to WT MRL/lpr mice. Relative expression of IL-18 and IL-1ƒÀ mRNA in the kidney were significantly decreased in Fli-1+/- MRL/lpr mice (p=0.02). In histological examination, glomerular inflammation was significantly decreased in Fli-1+/- MRL/lpr mice. However, interstitial inflammation was similar between the two groups. In contrast, immunostaining of IL-17 showed significantly decreased IL-17 positive immune cells in the kidney of Fli-1+/- MRL/lpr mice (Figure 1).

Conclusion: Fli-1 impacts lupus nephritis progression through affecting the reduction of IL-17-positive immune cell infiltration into the kidney. Reduced expression of IL-1ƒÀand IL-18 in the kidney can also affect IL-17 expression in Fli-1+/- MRL/lpr mice.


Disclosure: S. Sato, None; X. Zhang, None; Y. Fujita, None; M. Yashiro, None; T. Asano, None; H. Kobayashi, None; H. Watanabe, None; K. Migita, None.

To cite this abstract in AMA style:

Sato S, Zhang X, Fujita Y, Yashiro M, Asano T, Kobayashi H, Watanabe H, Migita K. Transcription Factor Fli-1 Impacts Renal IL-17 Expression in Adult MRL/Lpr Mouse Despite Similar Interstitial Immune Cell Infiltration into the Kidney [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/transcription-factor-fli-1-impacts-renal-il-17-expression-in-adult-mrl-lpr-mouse-despite-similar-interstitial-immune-cell-infiltration-into-the-kidney/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcription-factor-fli-1-impacts-renal-il-17-expression-in-adult-mrl-lpr-mouse-despite-similar-interstitial-immune-cell-infiltration-into-the-kidney/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology